Preadmission statin use and one-year mortality among patients in intensive care - a cohort study.

Crit Care · 2010 · PMC2887131 · PMID 20214779

Europe PMC DOI

hedged sentence

0.3500

closest p · 7.0× alpha

0.3500

boldest claim

The sentences

did not reach statistical significanceP = 0.35not close (p > 0.1)

The one-year reduction in risk of death remained robust in all diagnostic categories and seemed most pronounced for simvastatin (simvastatin MRR = 0.77, 95% CI = 0.70 to 0.85; atorvastatin MRR = 0.90, 95% CI = 0.72 to 1.12; pravastatin MRR = 1.03, 95% CI = 0.81 to 1.31); however, the difference between statins did not reach statistical significance ( P = 0.35).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.